Home LiteratureArticle Details
PMID: 6177233 Published · ppublish English Clinical Trial Journal Article

Interferon in cancer: Faith, hope and reality.

American journal of clinical oncology ·Vol. 5 ·No. 3 ·1982-06-00 ·Pages 297-301

Strander H, Einhorn S

Abstract

Patients that have received interferon therapy for tumor diseases to date do not total more than a few hundred. Remissions have been reported in some patients with various types of malignant tumors. This is interesting, as interferon therapy represents a new principle in the treatment of tumor diseases. However, prolonged and complete remissions have been rare, and we are not yet in a position to say whether interferon therapy is superior to other treatment methods in current use for any type of malignant tumor. If this proves to be the case for some such diseases, we would still be faced with the tasks of identifying patients that may benefit from the interferon treatment, and of establishing the best procedure for its application. Research toward these ends would be greatly facilitated by the development of methods for producing interferon.

MeSH Terms
Clinical Trials as Topic Female Humans Interferons/therapeutic use Neoplasms/therapy Remission, Spontaneous
Chemicals
Interferons
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Strander H
Einhorn S
Article Info
Journal
American journal of clinical oncology
Abbr.
Am J Clin Oncol
ISSN
0277-3732
Published
1982-06-00
Pages
297-301
Language
English
Region
United States
NLM ID
8207754
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]